Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8879772.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 14-year-old girl with HIV infection and subcutaneous Kaposi's sarcoma (KS) received thalidomide therapy for oral ulcers, resulting in regression of KS lesions, disappearance of KS-associated herpesvirus (KSHV) DNA from blood, and reduced viral load in tumor tissue. Administration of grauntocyte colony-stimulating factor resulted in clinical exacerbation of KS and reappearance of KSHV DNA in blood.
Medical subject headings
- HIV Infections
- Herpesvirus 8, Human
- Immunosuppressive Agents
- Sarcoma, Kaposi
- Thalidomide